Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcellx Inc COMMON STOCK | 1,047,557 | 1,047,557 | 0 | $80.34M | $68.72M | 81.77% | -$11.62M |
| Kymera Therapeutics, Inc.(KYMR) | 457,059 | 457,059 | 0 | $18.39M | $12.51M | 14.88% | -$5.88M |
| Seer, Inc.CL A(SEER) | 816,375 | 816,375 | 0 | $1.89M | $1.38M | 1.64% | -$506.2K |
| Rallybio Corporation(RLYB) | 754,678 | 754,678 | 0 | $724.5K | $493.9K | 0.59% | -$230.6K |
| Xilio Therapeutics, Inc.(XLO) | 667,742 | 667,742 | 0 | $637.7K | $483.7K | 0.58% | -$154.0K |
| Carisma Therapeutics Inc | 718,332 | 718,332 | 0 | $300.8K | $222.7K | 0.26% | -$78.2K |
| Rapt Therapeutics Inc | 99,503 | 99,503 | 0 | $157.2K | $121.4K | 0.14% | -$35.8K |
| Sutro Biopharma, Inc.(STRO) | 175,000 | 175,000 | 0 | $322.0K | $113.9K | 0.14% | -$208.1K |